Fig. 1 | Scientific Reports

Fig. 1

From: ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B

Fig. 1

Differentiated nuclear-cytoplasmic expression of KAT6A in FBD (A) and IDC (C), and nuclear expression of KAT6B in FBD (B) and IDC (D) cases. Original magnification, ×400. KAT6A and KAT6B IHC reactions statistical analysis in FBD (n = 38) and IDC (n = 495) cases. Analysis of cytoplasmic and nuclear KAT6A expression levels (E) (p < 0.0001, Mann-Whitney test). KAT6B’s significantly higher expression level between IDC and FBD samples (p < 0.0001, Mann-Whitney test) – (F). KAT6A’s and KAT6B’s expression in IDC with regard to malignancy Grade (G and H), respectively. *p < 0.1; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.

Back to article page